Arrow Group (Abbreviated New Drug Applications) Overview

  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • Asset Purch.
  • Financing Rounds
  • 1

Arrow Group (Abbreviated New Drug Applications) General Information

Description

Rights to Abbreviated New Drug Applications. It includes ANDA for Cabergoline from Watson and ANDA for Dronabinol from Cobalt Pharmaceuticals.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Clonshaugh Business and Technology Park
  • Coolock
  • Dublin D17 E400
  • Ireland
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arrow Group (Abbreviated New Drug Applications) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Arrow Group (Abbreviated New Drug Applications)‘s full profile, request access.

Request a free trial

Arrow Group (Abbreviated New Drug Applications) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Arrow Group (Abbreviated New Drug Applications)‘s full profile, request access.

Request a free trial